THIS IS A POST BY MATTY HARTON, THANK YOU MATTY FOR LETTING ME SHARE YOUR WEALTH OF KNOWLEDGE. ONE LOVE MY FRIEND

ABSTRACT

Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3.

http://www.google.com/patents/US6630507

This is a simple poster which explains the functionality of each area of the brain with an active cb1 receptor presence.

These areas, with their high concentration of cannabinoid receptor ligands, interact with the chemicals from the cannabis plant, allowing for a multitude of medicinal effects.

Cannabinoids have a naturally slippery nature, allowing them to pass through the blood brain barrier with ease, which gives cannabinoids the ability to attach to cancer cells deep within the structure of the brain, activating cellular apoptosis whilst protecting healthy cells.

Cannabinoids as antioxidants and neuroprotectants

US PATENT #6630507 B1